Lantheus Holdings, Inc. (LNTH) Social Stream



Lantheus Holdings, Inc. (LNTH): $64.73

1.23 (+1.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Lantheus Holdings Inc (LNTH) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Lantheus Holdings Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-21 2 $40 $34 $37 $58.36 -36.6%
2022-01-24 2 $40.001 $34 $37 $58.36 -36.6%
2022-02-24 2 $75 $55 $65 $58.36 11.38%
2022-03-14 2 $75 $60 $67.5 $58.36 15.66%

The Trend in the Analyst Price Target


Over the past 14 months, LNTH's average price target has gone up $48.75.

Over the past 48 weeks, LNTH's average upside potential has been 20.33%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 3 31.000 24 27.5 24.30 13.17%
2021-08-14 4 34.000 30 32.0 25.52 25.39%
2021-09-18 4 34.000 30 32.0 25.60 25%
2022-01-06 2 40.001 34 37.0 27.62 33.96%
2022-02-24 2 75.000 55 65.0 40.15 61.89%

LNTH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 151 days, LNTH's average broker recommendation rating improved by 0.33.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LNTH as an investment opportunity.

  • LNTH has a higher number of analysts covering the stock than 18.84% of all US stocks.
  • LNTH has a greater upside potential (average analyst target price relative to current price) than 14.77% of Pharmaceutical Products stocks.
  • LNTH has a lower variance in analysts' estimates than 36.07% of Pharmaceutical Products stocks.
  • In terms of how Lantheus Holdings Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 273.18% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Lantheus Holdings Inc are HSKA, CLDX, and ZYME.

Make investment decisions regarding LNTH using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4256 seconds.